|
To assess the efficacy, immuno & safety of 2 doses of GSK HRV vaccine at different virus concentrations in healthy infants aged 2 months & previously uninfected with HRV, concurrently given with DTPw-HBV, Hib. |
Rotavirus Vaccine |
444563/006 |
NCT00385320 |
Infections, Rotavirus |
Phase 2 |
|
|
|
|
An annotated case report form is not available for this study. A blank case report form will be provided. |
June 2015 |